Home Companies Cirius Therapeutics COMPANY
Past trials only
Keywords: metabolic type 2 diabetes mellitus obesity NASH - Nonalcoholic Steatohepatitis Non-Alcoholic Fatty Liver Disease Type2 Diabetes Nonalcoholic Steatohepatitis Non-alcoholic Steatohepatitis MSDC-0602K Show all 9 keywords
Profile checked Oct 10, 2026
At a glance Stage Past trials only Latest trial Phase 3: A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D… (2022-06) source Timeline 2022-06 Trial start Phase 3: A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH source ↗ Sep 14, 2016 Trial start Phase 2: A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH source ↗ Clinical trials (lead sponsor) 2 Record Title Phase Status Start Primary completion NCT03970031 A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH Phase 3 Unknown status (ClinicalTrials.gov) 2022-06 2024-09 (estimated) NCT02784444 A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH Phase 2 Completed Sep 14, 2016 2019-06 (actual)
